Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · IEX Real-Time Price · USD

13.25

+0.24 (1.84%)

At close: Apr 25, 2024, 4:00 PM

13.30

+0.05 (0.38%)

After-hours: Apr 25, 2024, 7:30 PM EDT

Teva Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Revenue	15,846	14,925	15,878	16,659	16,887	18,271	21,853	21,903	19,652	20,272	Upgrade
Revenue Growth (YoY)	6.17%	-6.00%	-4.69%	-1.35%	-7.57%	-16.39%	-0.23%	11.45%	-3.06%	-0.21%	Upgrade
Cost of Revenue	8,200	7,952	8,284	8,933	9,351	9,975	11,237	10,250	8,296	9,216	Upgrade
Gross Profit	7,646	6,973	7,594	7,726	7,536	8,296	10,616	11,653	11,356	11,056	Upgrade
Selling, General & Admin	3,498	3,445	3,528	3,671	3,806	4,214	4,846	4,973	4,838	5,078	Upgrade
Research & Development	953	838	967	997	1,010	1,213	1,778	2,077	1,525	1,488	Upgrade
Other Operating Expenses	2,762	4,887	1,384	6,629	3,164	4,506	21,475	2,449	1,641	539	Upgrade
Operating Expenses	7,213	9,170	5,879	11,297	7,980	9,933	28,099	9,499	8,004	7,105	Upgrade
Operating Income	433	-2,197	1,715	-3,571	-444	-1,637	-17,483	2,154	3,352	3,951	Upgrade
Interest Expense / Income	1,057	966	1,058	834	822	959	895	1,330	1,000	313	Upgrade
Other Expense / Income	-58	-74	29	-247	11	-251	-180	-26	130	-8	Upgrade
Pretax Income	-566	-3,089	628	-4,158	-1,277	-2,345	-18,198	850	2,222	3,646	Upgrade
Income Tax	-7	-643	211	-168	-278	-195	-1,933	521	634	591	Upgrade
Net Income	-559	-2,446	417	-3,990	-999	-2,150	-16,265	329	1,588	3,055	Upgrade
Preferred Dividends	0	0	0	0	0	249	260	261	15	0	Upgrade
Net Income Common	-559	-2,446	417	-3,990	-999	-2,399	-16,525	68	1,573	3,055	Upgrade
Net Income Growth	-	-	-	-	-	-	-	-95.68%	-48.51%	140.74%	Upgrade
Shares Outstanding (Basic)	1,119	1,110	1,102	1,095	1,091	1,021	1,016	955	855	853	Upgrade
Shares Outstanding (Diluted)	1,119	1,110	1,107	1,095	1,091	1,021	1,016	961	864	858	Upgrade
Shares Change	0.81%	0.27%	1.10%	0.37%	6.86%	0.49%	5.72%	11.23%	0.70%	0.94%	Upgrade
EPS (Basic)	-0.50	-2.20	0.38	-3.64	-0.91	-2.35	-16.26	0.07	1.84	3.58	Upgrade
EPS (Diluted)	-0.50	-2.20	0.38	-3.64	-0.91	-2.35	-16.26	0.07	1.82	3.56	Upgrade
EPS Growth	-	-	-	-	-	-	-	-96.15%	-48.88%	138.93%	Upgrade
Free Cash Flow	842	1,042	236	638	223	1,795	1,351	2,989	4,770	4,198	Upgrade
Free Cash Flow Per Share	0.75	0.94	0.21	0.58	0.20	1.76	1.33	3.13	5.58	4.92	Upgrade
Dividend Per Share	-	-	-	-	-	-	0.722	1.360	1.258	1.163	Upgrade
Dividend Growth	-	-	-	-	-	-	-46.91%	8.11%	8.17%	6.70%	Upgrade
Gross Margin	48.25%	46.72%	47.83%	46.38%	44.63%	45.41%	48.58%	53.20%	57.79%	54.54%	Upgrade
Operating Margin	2.73%	-14.72%	10.80%	-21.44%	-2.63%	-8.96%	-80.00%	9.83%	17.06%	19.49%	Upgrade
Profit Margin	-3.53%	-16.39%	2.63%	-23.95%	-5.92%	-13.13%	-75.62%	0.31%	8.00%	15.07%	Upgrade
Free Cash Flow Margin	5.31%	6.98%	1.49%	3.83%	1.32%	9.82%	6.18%	13.65%	24.27%	20.71%	Upgrade
Effective Tax Rate	-	-	33.60%	-	-	-	-	61.29%	28.53%	16.21%	Upgrade
EBITDA	1,644	-815	3,016	-1,767	1,267	456	-15,191	3,704	4,530	5,467	Upgrade
EBITDA Margin	10.37%	-5.46%	18.99%	-10.61%	7.50%	2.50%	-69.51%	16.91%	23.05%	26.97%	Upgrade
Depreciation & Amortization	1,153	1,308	1,330	1,557	1,722	1,842	2,112	1,524	1,308	1,508	Upgrade
EBIT	491	-2,123	1,686	-3,324	-455	-1,386	-17,303	2,180	3,222	3,959	Upgrade
EBIT Margin	3.10%	-14.22%	10.62%	-19.95%	-2.69%	-7.59%	-79.18%	9.95%	16.40%	19.53%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).